New Investigation of Ventrus Biosciences, Inc. (NASDAQ: VTUS)

Haeggquist & Eck, LLP has commenced an investigation into Ventrus Biosciences, Inc. (“Ventrus”), to determine whether it has violated securities laws by issuing false and misleading statements to its shareholders.

Ventrus is a specialty pharmaceutical company that focuses on the development of prescription drugs for gastrointestinal disorders.  On June 25, 2012, Ventrus announced the results of its Phase 3 placebo-controlled trial of its experimental drug iferanserin, also known as VEN 309.  The trial results showed that VEN 309 failed to demonstrate an improvement in therapy in patients with hemorrhoidal disease, and Ventrus announced that had no immediate plans to continue the development of VEN 309.

Upon this announcement, the price of Ventrus stock declined from as high as $12.26 per share on June 22, 2012, to as low as $4.27 on June 29, 2012, and continued to decline to as low as $2.06 per share on November 13, 2012.

Our investigation focuses on whether statements made by Ventrus to the investing public regarding the effectiveness and commercial prospects for VEN 309 were materially false and misleading at the time they were made.

If you are a Ventrus Biosciences, Inc. shareholder who purchased Ventrus common stock between December 17, 2010, and June 22, 2012, you may have claims under the securities laws.  If you wish to discuss this investigation or have questions about this notice or your legal rights, please contact attorney Amber L. Eck at (619) 342-8000.

To schedule your free initial consultation, contact us online or call (619) 342-8000 today!



Related Posts

Class Action Suit Against SDSU

Haeggquist & Eck, LLP Title IX Clients Featured on ESPN for Class Action Suit Against SDSU

Haeggquist & Eck are proud to team up with Bailey Glasser to represent former and current SDSU athletes in their …

Read More

HAE Client “Dr. Nick” Yphantides Highlighted In Media Coverage Of Disability Discrimination Case Against San Diego County

Local and national media outlets covered our client Nick Yphantides’ case against the County of San Diego for disability discrimination, …

Read More

California Judge Rules Ballot Initiative Classifying App-Based Drivers As Independent Contractors Is Unconstitutional

Proposition 22, the controversial California ballot measure classifying app-based drivers as independent contractors, hit another roadblock on Friday after a …

Read More
Translate »